89 results
8-K
EX-99.1
NRBO
NeuroBo Pharmaceuticals Inc
9 May 24
NeuroBo Pharmaceuticals Reports First Quarter 2024 Financial Results
8:05am
are expected to be available in the fourth quarter of 2024.
First Quarter Financial and Operating Results
Research and Development (R&D) Expenses were … Ended March 31,
Operating expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income
8-K
EX-99.1
n5q3l3lrh07p1hor
28 Mar 24
NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
8:01am
8-K
EX-99.1
19ahb
13 Nov 23
NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-99.1
m72dbst 3ex5vyt6o9w0
6 Nov 23
Departure of Directors or Certain Officers
8:20am
8-K
EX-99.1
5koovftfgv67wxtuo3a
14 Aug 23
Neurobo Pharmaceuticals Appoints Hyung Heon Kim
8:18am
8-K
iw4oq19uiu6
14 Aug 23
Neurobo Pharmaceuticals Appoints Hyung Heon Kim
8:18am
8-K
EX-99.1
lccfd4g65hob5jz9w5
9 Aug 23
NeuroBo Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:20pm
8-K
EX-99.1
s97gl
30 Mar 23
NeuroBo Pharmaceuticals Reports Full Year 2022 Financial Results
4:47pm
424B4
8r4ks jdr8qsdud
7 Nov 22
Prospectus supplement with pricing info
9:07am